Related Experiment Videos
Hb Gunma (beta Gunma) with pulmonary embolism
Internal Medicine (Tokyo, Japan)
|May 1, 1995
Summary
A novel hemoglobinopathy, Hb Gunma, was identified in a patient with pulmonary embolism. This rare genetic blood disorder results in hemolytic anemia, despite normal hemoglobin levels in circulation.
Area of Science:
- Hematology
- Genetics
- Molecular Biology
Background:
- Beta-thalassemia is a genetic blood disorder characterized by reduced or absent synthesis of beta-globin chains.
- Microcytosis and hemolysis are common indicators of thalassemia, prompting further investigation.
Observation:
- A 67-year-old woman presented with pulmonary embolism, microcytosis, and hemolysis.
- Standard red cell stability tests were negative, suggesting an atypical cause.
Findings:
- DNA sequencing revealed a novel mutation in the beta-globin gene, a three-nucleotide deletion causing Hb Gunma.
- Hb Gunma results in the substitution of specific amino acids, leading to a thalassemic hemoglobinopathy.
- Despite the mutation, no abnormal hemoglobin was detected in the patient's blood, presenting a unique diagnostic challenge.
Implications:
- This case expands the spectrum of known thalassemic hemoglobinopathies.
- Understanding Hb Gunma is crucial for accurate diagnosis and management of unexplained hemolytic anemia.
- Further research into the molecular mechanisms of Hb Gunma may reveal new therapeutic targets.